|
Market Closed -
Canadian Securities Exchange
15:51:08 2026-09-22 EDT
|
5-day change | 1st Jan Change | ||
| 0.0900 CAD | +38.46% |
|
+38.46% | -10.00% |
Company Valuation: Biosenta Inc.
Data adjusted to current consolidation scope
| Fiscal Period: September | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 4.856 | 10.27 | 9.216 | 11.09 | 2.87 | 4.06 |
| Change | - | 111.55% | -10.28% | 20.34% | -74.12% | 41.46% |
| Enterprise Value (EV) 1 | 5.606 | 11.37 | 10.82 | 16.7 | 8.413 | 10.67 |
| Change | - | 102.75% | -4.85% | 54.44% | -49.63% | 26.79% |
| P/E | -5.88x | -4.62x | -5.84x | -1.74x | -1.19x | -1.59x |
| PBR | -2.6x | -3.96x | -3.15x | -1.41x | -0.36x | -0.41x |
| PEG | - | -0x | 0.1x | -0x | 0x | 35.24x |
| Capitalization / Revenue | 3,174x | 61.1x | 8,007x | 10,644x | 2,081x | 3,352x |
| EV / Revenue | 3,664x | 67.6x | 9,397x | 16,030x | 6,101x | 8,809x |
| EV / EBITDA | - | - | - | - | - | - |
| EV / EBIT | -7.96x | -5.66x | -8.88x | -11.3x | -7.62x | -8.67x |
| EV / FCF | -32.4x | 924x | -11.2x | 140x | -6.75x | -424x |
| FCF Yield | -3.08% | 0.11% | -8.89% | 0.71% | -14.8% | -0.24% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0476 | -0.1147 | -0.0685 | -0.2409 | -0.0754 | -0.0753 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 0.00153 | 0.1681 | 0.001151 | 0.001042 | 0.001379 | 0.001211 |
| EBITDA | - | - | - | - | -1.101 | -1.228 |
| EBIT 1 | -0.7045 | -2.008 | -1.218 | -1.483 | -1.104 | -1.23 |
| Net income 1 | -0.7619 | -2.042 | -1.458 | -6.3 | -2.228 | -2.506 |
| Net Debt 1 | 0.7506 | 1.095 | 1.599 | 5.613 | 5.543 | 6.608 |
| Reference price 2 | 0.2800 | 0.5300 | 0.4000 | 0.4200 | 0.0900 | 0.1200 |
| Nbr of stocks (in thousands) | 17,342 | 19,381 | 23,040 | 26,407 | 31,889 | 33,831 |
| Announcement Date | 1/28/21 | 1/27/22 | 1/27/23 | 1/29/24 | 1/28/25 | 1/28/26 |
1CAD in Million2CAD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 2.41M | |
| 17.15x | 3.07x | 11.08x | 4.36% | 41.82B | |
| 25.94x | 3.94x | 16.83x | 1.29% | 22.78B | |
| 14.71x | 1.97x | 10.75x | 6.09% | 10.15B | |
| 13.55x | 1.58x | 8.99x | 4.17% | 4.62B | |
| 14.57x | 1.68x | 10.04x | 10.12% | 3.47B | |
| 18.7x | 0.9x | 6.85x | 1.97% | 3.02B | |
| 32.2x | 3.97x | 21.6x | - | 2.68B | |
| Average | 19.54x | 2.44x | 12.31x | 4.67% | 11.07B | |
| Weighted average by Cap. | 19.35x | 2.99x | 12.54x | 3.89% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ZRO Stock
- Valuation Biosenta Inc.
Select your edition
All financial news and data tailored to specific country editions
